Emil T. Kuriakose
Corporate Officer/Principal chez TERNS PHARMACEUTICALS, INC.
Fortune : 353 121 $ au 31/05/2024
Postes actifs de Emil T. Kuriakose
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2023 | - |
Historique de carrière de Emil T. Kuriakose
Anciens postes connus de Emil T. Kuriakose
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Directeur Technique/Scientifique/R&D | 01/07/2013 | 01/01/2016 |
| CALITHERA BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 01/08/2017 | - |
Formation de Emil T. Kuriakose
| Stony Brook University School of Medicine | Doctorate Degree |
| New York University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| TERNS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
- Bourse
- Insiders
- Emil T. Kuriakose
- Expérience
